BCH Stock Falls Again as Earnings Misses Pile Up

Bangkok Chain Hospital PCL (BCH) continues to face downward pressure in the stock market, with a 7.42% decline over the past seven days. As of April 2, 2026, the stock trades at $445.1 after falling 2.11% in the last 24 hours. Over a one-month period, the stock has lost 4.5%, and its price has dropped by 25.69% in the last year. The recent earnings releases have shown a consistent pattern of underperformance, with actual results frequently falling short of forecasts.

The company is scheduled to release earnings for the March 2026 quarter on May 15, 2026. Historical earnings data reveals a recurring trend of negative surprises. In December 2025, for example, earnings per share (EPS) came in at 0.1, below the forecast of 0.14, representing a 28.57% miss. Revenue also fell short by 2.62%, and the stock dropped 9.65% in the following period. Similar patterns were observed in the September 2025 and June 2025 quarters, where the company missed both EPS and revenue estimates, contributing to continued investor pessimism.

The earnings data highlights the challenges the company faces in meeting market expectations. While the company reported revenue of THB2.97 billion in December 2025, it fell short of the projected THB3.05 billion. Over the past two years, the stock has seen a mix of positive and negative earnings surprises. The most notable positive surprise occurred in June 2025, where EPS exceeded the forecast by 14.29%, though the stock still declined by 6.38% in the following period. This suggests that the market may be pricing in broader operational concerns rather than just short-term earnings misses.

Investor sentiment has been further impacted by the company’s inability to consistently beat estimates. The September 2024 quarter saw a modest EPS miss of 2.70%, and the stock rose slightly by 1.86%. However, this positive outcome appears to be an exception rather than the rule, as the trend has largely remained negative. The repeated earnings underperformance raises concerns about the company's ability to sustain profitability and drive growth in a competitive sector.

The forward-looking financial expectations for the company remain uncertain, as the market continues to react to ongoing earnings disappointments. With limited recent data on future forecasts and a lack of significant earnings upside in recent periods, the stock remains under pressure. Analysts have not provided clear projections for the March 2026 earnings, adding to the uncertainty surrounding the company's near-term performance.

Overall, the earnings history and market performance suggest a continued lack of confidence in the company's ability to deliver consistent results. Until there is a clear turnaround in earnings surprises and a demonstration of stronger operational momentum, the stock is likely to remain volatile. Investors are closely watching the May 15 earnings report for signs of improvement, though the historical pattern indicates a cautious outlook.